Use of Moisturizers and Lubricants for Vulvovaginal Atrophy.

Ayane Cristine Alves Sarmento,José Eleutério,Márcia Farina Kamilos,Ana Katherine Gonçalves,Ana Paula Ferreira Costa,Pedro Vieira-Baptista

doi:10.3389/frph.2021.781353

Abstract

The estrogen decrease in postmenopausal women results in functional and anatomical changes in the genitourinary tract. The most prevalent and bothersome symptoms are vaginal dryness, dyspareunia, and reduced lubrication, which can significantly affect the quality of life of these women, principally those who are sexually active. Hormonal therapy with local estrogens is generally considered the “gold standard.” However, there are cases in which there are clinical concerns about its use or women opt for non-hormonal options. Thus, safe and effective non-hormonal options are needed to improve symptoms in these women. Moisturizers and lubricants are first-line therapy for breast cancer survivors.

Highlights

Vulvovaginal atrophy (VVA) is one of the most striking and acknowledged manifestations of the so-called “genitourinary syndrome of menopause” (GSM), and can get worse if not treated [1, 2]
The intensity of symptoms is related to the time elapsed since menopause and the frequency of sexual intercourse [3, 4]
Many women try to alleviate postmenopausal symptoms with over-the-counter products, like moisturizers or lubricants, while others seek the help of a gynecologist or other health care professionals [6]

Summary

Use of Moisturizers and Lubricants for Vulvovaginal Atrophy

Ayane Cristine Alves Sarmento 1*, Márcia Farina Kamilos 2, Ana Paula Ferreira Costa 1, Pedro Vieira-Baptista 3,4, José Eleutério Jr. 5 and Ana Katherine Gonçalves 1,6. The estrogen decrease in postmenopausal women results in functional and anatomical changes in the genitourinary tract. The most prevalent and bothersome symptoms are vaginal dryness, dyspareunia, and reduced lubrication, which can significantly affect the quality of life of these women, principally those who are sexually active. Hormonal therapy with local estrogens is generally considered the “gold standard.”. There are cases in which there are clinical concerns about its use or women opt for non-hormonal options. Safe and effective non-hormonal options are needed to improve symptoms in these women. Moisturizers and lubricants are first-line therapy for breast cancer survivors

INTRODUCTION

VAGINAL MOISTURIZERS

CONCLUSION

AUTHOR CONTRIBUTIONS